A Florida jury convicted a health executive who billed Medicare over $1 billion for gear patients never needed

Reception hotel and senior couple on vacation or elderly person at concierge desk or check in with lobby receptionist or secretary Black woman working in hospitality and help people in retirement

A Florida jury convicted Brett Blackman, owner of the health care software company HealthSplash, of conspiracy to defraud Medicare through a scheme that generated more than $1 billion in false claims for durable medical equipment patients never needed. The conviction follows a trial in the Southern District of Florida and adds to a string of guilty verdicts tied to the same operation, which prosecutors say used a digital platform called DMERx to mass-produce fake doctors’ orders, pay kickbacks, and bill federal health programs for orthotic braces and other gear. Payors paid out more than $360 million before the scheme collapsed.

How a software platform scaled Medicare billing fraud

The scheme ran from approximately February 2015 to October 2020, according to the Justice Department summary of the case against Blackman. During that span, Blackman and his co-conspirators built DMERx into what prosecutors described as a digital health platform that industrialized fraud. Rather than relying on individual corrupt doctors or a handful of billing clerks, the platform automated the generation of prescriptions and claims submissions at a volume that dwarfed older manual schemes.

Suppliers and pharmacies that plugged into DMERx billed Medicare more than $1 billion for items including multiple orthotic braces coded under specific HCPCS billing categories. To feed the pipeline, the operation recruited patients through mailers, television advertisements, and offshore call centers that pitched “free” or low-cost medical equipment. Doctors’ orders attached to those claims were false, prosecutors said, created without legitimate medical evaluations or meaningful patient contact. Kickbacks flowed to the suppliers and marketers who kept the billing volume high, with payments disguised as consulting fees and other sham arrangements.

Evidence at trial showed that HealthSplash and DMERx functioned as the technological hub for this activity. The software matched leads from call centers with physicians willing to sign orders, generated templated documentation, and routed electronic prescriptions to durable medical equipment suppliers. Participants actively concealed the operation by removing what prosecutors called “dangerous words” from internal records, a tactic designed to make the platform’s output look routine if audited. The result was a system where software did the heavy lifting that once required dozens of people committing individual acts of paperwork fraud.

Blackman was not the only executive swept up in the case. Gary Cox, who served as CEO of DMERx, was convicted in a separate trial arising from the same conduct. According to a press release from the U.S. Attorney’s Office in the Southern District of Florida, Cox oversaw day‑to‑day operations that connected physicians, telemarketing outfits, and suppliers. Another defendant, Gregory Schreck, was also charged in the conspiracy. Together, the group turned what looked like a modern telehealth and practice‑management platform into a high‑volume engine for fraudulent billing.

What the $360 million payout reveals about enforcement gaps

The gap between the more than $1 billion billed and the more than $360 million actually paid out by federal health programs points to a detection problem that took years to close. The scheme operated for roughly five and a half years before it ended in October 2020, and the criminal case was not filed until 2023. That lag matters because every month the platform ran, Medicare processed claims that diverted taxpayer dollars from legitimate patient care, even if some claims were denied or later clawed back.

Claims data analytics and prior authorization rules stopped a portion of the attempted fraud, but the remaining losses show the limits of existing safeguards when technology is used to multiply questionable claims. Automated systems can flood Medicare contractors with documentation that appears facially compliant, making it harder for reviewers to distinguish genuine medical need from scripted paperwork. In that environment, even a relatively low approval rate can translate into hundreds of millions of dollars in improper payments.

The Justice Department’s National Fraud Enforcement Division framed the Blackman conviction as part of a broader enforcement push aimed at tech‑enabled health care scams. In a separate announcement, officials highlighted that the division’s Healthcare Fraud Unit recently secured six trial convictions involving more than $1.1 billion in alleged fraud in under three weeks. That pace signals a shift in how federal prosecutors are packaging and trying these cases, grouping related defendants, emphasizing data‑driven evidence, and moving quickly through trial calendars to keep up with emerging schemes.

The scale also raises a practical question for anyone enrolled in Medicare. When billions of dollars in fraudulent claims move through the system, the costs eventually land on beneficiaries through higher premiums and pressure on program solvency. Patients whose names appeared on false orders may also face complications with their own medical records, since items they never used can show up as part of their treatment history. That can confuse future providers, complicate coverage decisions, and, in some cases, trigger additional scrutiny of legitimate claims.

For policymakers, the Blackman case underscores the need to treat health care software not just as a neutral tool but as a potential risk vector. Regulators and contractors are likely to increase oversight of platforms that sit between physicians, marketers, and suppliers, particularly when those platforms control referral flows and documentation templates. Stronger transparency requirements around ownership, revenue sharing, and clinical decision pathways could make it harder for similar schemes to hide behind the language of innovation.

As sentencing approaches, Blackman faces the prospect of a lengthy prison term and substantial financial penalties. Whatever the final punishment, the case stands as a warning that digital infrastructure can amplify fraud just as easily as it can improve access to care-and that enforcement agencies are racing to adapt their strategies to that reality.

Leave a Reply

Your email address will not be published. Required fields are marked *